IL22 and lymphangioma: To determine the impact of IL-22 on bacterial clearance during a secondary mucosal LM infection, B6 and IL-22 KO mice were re-infected via the mucosal i.g. route of infection six weeks after a primary mucosal LM/strepr infection.